Leginsulin Peptide from Legumes as a Ligand of Growth Hormone-Releasing Hormone Receptor for Lipodystrophy Management in Patients with AIDS Leginsulin as a ligand of GHRH Receptor for
Trends in Peptide and Protein Sciences,
Vol. 7 (2022),
7 March 2022
,
Page 1-7 (e5)
https://doi.org/10.22037/tpps.v7i.38445
Abstract
Since the appearance of acquired immunodeficiency syndrome (AIDS) disease, millions of people got infected, thousands are died and many suffered from its complications. One of the chronic and late symptoms of AIDS is lipodystrophy that leads to losing of fat in some parts of the body while gaining it at other organs and sites. One of the main targets in drug development for management of lipodystrophy is growth hormone-releasing hormone (GHRH) receptor. As a secondary metabolite from plants, leginsulin is a peptide with 37 amino acids and considered as hormone-like peptide. In this study, through in silico approaches, binding of leginsulin and GHRH receptor was studied. The results showed strong binding of the two molecules with docking score of -324.16 and ligand RMSD of 47.26. The molecular dynamic investigation also revealed these two proteins remained bound for almost 104 ns. Evaluation of the peptide toxicity in the body had shown that it is not toxic to the human organs and also, it doesn’t pass through the blood brain barrier. The results support the use of legumes as a source of leginsulin for potential management of lipodystrophy in the patients with AIDS.
HIGHLIGHTS
- Leginsulin is a plant secondary metabolite with 37 amino acids peptide structure.
- Binding of leginsulin and GHRH receptor was studied through in silico approaches.
- Results support the leginsulin as a potential management of lipodystrophy in AIDS patients.
- AIDS
- Leginsulin
- Lipodystrophy
- Peptides
- Protein docking
How to Cite
References
Abbott, N.J., Patabendige, A.A., Dolman, D.E., Yusof, S.R. and D.J. Begley, (2010). ″Structure and function of the blood–brain barrier.″ Neurobiology of Disease, 37(1): 13-25. DOI: https://doi.org/10.1016/j.nbd.2009.07.030.
Abdulhameed, M.D.M., Liu, R., Schyman, P., Sachs, D., Xu, Z., Desai, V. and A. Wallqvist, (2021). ″ToxProfiler: Toxicity-target profiler based on chemical similarity.″ Computational Toxicology, 18: 100162. DOI: https://doi.org/10.1016/j.comtox.2021.100162.
Carr, A., Samaras, K., Burton, S., Law, M., Freund, J., Chisholm, D.J. and D.A. Cooper, (1998). ″A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors.″ AIDS, 12(7): F51-58. DOI: https://doi.org/10.1097/00002030-199807000-00003.
Danaeifar, M. and M.A. Mazlomi, (2022). ″Combinatorial biosynthesis: playing chess with the metabolism.″ Journal of Asian Natural Products Research, 1-20. DOI: https://doi.org/10.1080/10286020.2022.2065265.
De Medeiros, A.F., De Queiroz, J.L.C., Maciel, B.L.L. and A.H. De Araújo Morais, (2022). ″Hydrolyzed proteins and vegetable peptides: anti-inflammatory mechanisms in obesity and potential therapeutic targets.″ Nutrients, 14(3): 690. DOI: https://doi.org/10.3390/nu14030690.
Diao, L. and B. Meibohm, (2013). ″Pharmacokinetics and pharmacokinetic–pharmacodynamic correlations of therapeutic peptides.″ Clinical Pharmacokinetics, 52: 855-868. DOI: https://doi.org/10.1007/s40262-013-0079-0.
Finkelstein, J.L., Gala, P., Rochford, R., Glesby, M.J. and S. Mehta, (2015). ″HIV/AIDS and lipodystrophy: implications for clinical management in resource‐limited settings.″ Journal of the International AIDS Society, 18(1): 19033. DOI: https://doi.org/10.7448/IAS.18.1.19033.
Fiorenza, C.G., Chou, S.H. and C.S. Mantzoros, (2011). ″Lipodystrophy: pathophysiology and advances in treatment.″ Nature Reviews Endocrinology, 7: 137-150. DOI: https://doi.org/10.1038/nrendo.2010.199.
Galescu, O., Bhangoo, A. and S. Ten, (2013). ″Insulin resistance, lipodystrophy and cardiometabolic syndrome in HIV/AIDS.″ Reviews in Endocrine and Metabolic Disorders, 14: 133-140. DOI: https://doi.org/10.1007/s11154-013-9247-7.
Gonzalez, E., Jain, S., Shah, P., Torimoto-Katori, N., Zakharov, A., Nguyễn, Ð.-T., Sakamuru, S., Huang, R., Xia, M. and R.S. Obach, (2021). ″Development of robust quantitative structure-activity relationship models for CYP2C9, CYP2D6, and CYP3A4 Catalysis and Inhibition.″ Drug Metabolism and Disposition, 49(9): 822-832. DOI: https://doi.org/10.1124/dmd.120.000320.
Granich, R., Gupta, S., Hersh, B., Williams, B., Montaner, J., Young, B. and J.M. Zuniga, (2015). ″Trends in AIDS deaths, new infections and ART coverage in the top 30 countries with the highest AIDS mortality burden; 1990–2013.″ PLoS One, 10(7): e0131353. DOI: https://doi.org/10.1371/journal.pone.0131353.
GrinspooN, S. and M. Gelato, (2001). ″The rational use of growth hormone in HIV-infected patients.″ The Journal of Clinical Endocrinology and Metabolism, 86(8): 3478-3479. DOI: https://doi.org/10.1210/jcem.86.8.7879.
Guaraldi, G., Stentarelli, C., Zona, S. and A. Santoro, (2013). ″HIV-associated lipodystrophy: impact of antiretroviral therapy.″ Drugs, 73: 1431-1450. DOI: https://doi.org/10.1007/s40265-013-0108-1.
Husain, A., Makadia, V., Valicherla, G.R., Riyazuddin, M. and J.R. Gayen, (2022). ″Approaches to minimize the effects of P‐glycoprotein in drug transport: A review.″ Drug Development Research, 1-17. DOI: https://doi.org/10.1002/ddr.21918.
Jedlowski, P.M., Te, C.H., Segal, R.J. and M.T. Fazel, (2019). ″Cutaneous adverse effects of diabetes mellitus medications and medical devices: a review.″ American Journal of Clinical Dermatology, 20: 97-114. DOI: https://doi.org/10.1007/s40257-018-0400-7.
Ji, C., Svensson, F., Zoufir, A. and A. Bender, (2018). ″eMolTox: prediction of molecular toxicity with confidence.″ Bioinformatics, 34(14): 2508-2509. DOI: https://doi.org/10.1093/bioinformatics/bty135.
Kim, W.S., Jang, S. and H.B. Krishnan, (2012). ″Accumulation of leginsulin, a hormone‐like bioactive peptide, is drastically higher in asian than in north american soybean accessions.″ Crop Science, 52: 262-271. DOI: https://doi.org/10.2135/cropsci2011.08.0454.
Komatsu, S., Koshio, O. and H. Hirano, (1994). ″Protein kinase activity and insulin-binding activity in plant basic 7S globulin.″ Bioscience, Biotechnology, and Biochemistry, 58(9): 1705-1706. DOI: https://doi.org/10.1271/bbb.58.1705.
Lo, J., You, S.M., Canavan, B., Liebau, J., Beltrani, G., Koutkia, P., Hemphill, L., Lee, H. and S. Grinspoon, (2008). ″Low-dose physiological growth hormone in patients with HIV and abdominal fat accumulation: a randomized controlled trial.″ JAMA, 300(5):509-519. DOI: https://doi.org/10.1001/jama.300.5.509.
Marcel, A.-K., Ekali, L.G., Eugene, S., Arnold, O.E., Sandrine, E.D., Von Der Weid, D., Gbaguidi, E., Ngogang, J. and J.C. Mbanya, (2011). ″The effect of Spirulina platensis versus soybean on insulin resistance in HIV-infected patients: a randomized pilot study.″ Nutrients, 3(7): 712-724. DOI: https://doi.org/10.3390/nu3070712.
Peate, I. (2021). ″World AIDS Day 2021: a comparison of HIV and COVID-19.″ British Journal of Healthcare Assistants, 15: 506-509. DOI: https://doi.org/10.12968/bjha.2021.15.10.506.
Pike, C.J., Nguyen, T.-V.V., Ramsden, M., Yao, M., Murphy, M.P. and E.R. Rosario, (2008). ″Androgen cell signaling pathways involved in neuroprotective actions.″ Hormones and Behavior, 53(5): 693-705. DOI: https://doi.org/10.1016/j.yhbeh.2007.11.006.
Reinle, K., Mogk, A. and B. Bukau, (2022). ″The diverse functions of small heat shock proteins in the proteostasis network.″ Journal of Molecular Biology, 434(1): 167157. DOI: https://doi.org/10.1016/j.jmb.2021.167157.
Rietschel, P., Hadigan, C., Corcoran, C., Stanley, T., Neubauer, G., Gertner, J. and S. Grinspoon, (2001). ″Assessment of growth hormone dynamics in human immunodeficiency virus-related lipodystrophy.″ The Journal of Clinical Endocrinology and Metabolism, 86(2): 504-510. DOI: https://doi.org/10.1210/jcem.86.2.7175.
Scandlyn, J. (2000). ″When AIDS became a chronic disease.″ Western Journal of Medicine, 172(2): 130-133. DOI: https://doi.org/10.1136/ewjm.172.2.130.
Schuman, J.S., Orellana, J., Friedman, A.H. and S.A. Teich, (1987). Acquired immunodeficiency syndrome (AIDS). Survey of Ophthalmology, 31(6): 384-410. DOI: https://doi.org/10.1016/0039-6257(87)90031-2.
Schyman, P., Liu, R., Desai, V. and A. Wallqvist, (2017). ″vNN web server for ADMET predictions.″ Frontiers in Pharmacology, 8: 889. DOI: https://doi.org/10.3389/fphar.2017.00889
Shevitz, A., Wanke, C.A., Falutz, J. and D.P. Kotler, (2001). ″Clinical perspectives on HIV-associated lipodystrophy syndrome: an update.″ AIDS, 15(15): 1917-1930. DOI: https://doi.org/10.1097/00002030-200110190-00003
Sivakumar, T., Mechanic, O., Fehmie, D. and B. Paul, (2011). ″Growth hormone axis treatments for HIV‐associated lipodystrophy: a systematic review of placebo‐controlled trials.″ HIV Medicine, 12: 453-462. DOI: https://doi.org/10.1111/j.1468-1293.2010.00906.x.
Sorokina, M. and C. Steinbeck, (2019). ″NaPLeS: a natural products likeness scorer—web application and database.″ Journal of Cheminformatics, 11: 55. https://doi.org/10.1186/s13321-019-0378-z.
Thomas, P. and T.G. Smart, (2005). ″HEK293 cell line: a vehicle for the expression of recombinant proteins.″ Journal of Pharmacological and Toxicological Methods, 51(3): 187-200. DOI: https://doi.org/10.1016/j.vascn.2004.08.014.
Wang, Y. and B. Tomlinson, (2009). ″Tesamorelin, a human growth hormone releasing factor analogue.″ Expert Opinion on Investigational Drugs, 18(3): 303-310. DOI: https://doi.org/10.1517/13543780802707658
Wishart, D.S., Feunang, Y.D., Guo, A.C., Lo, E.J., Marcu, A., Grant, J.R., Sajed, T., Johnson, D., LI, C. and Z. Sayeeda, (2018). ″DrugBank 5.0: a major update to the DrugBank database for 2018.″ Nucleic Acids Research, 46(D1): D1074-D1082. DOI: https://doi.org/10.1093/nar/gkx1037.
Yamazaki, T., Takaoka, M., Katoh, E., Hanada, K., Sakita, M., Sakata, K., Nishiuchi, Y. and H. Hirano, (2003). ″A possible physiological function and the tertiary structure of a 4‐kDa peptide in legumes.″ European Journal of Biochemistry, 270(6): 1269-1276. DOI: https://doi.org/10.1046/j.1432-1033.2003.03489.x.
Yan, Y., Tao, H., He, J. and S.-Y. HuaNG, (2020). ″The HDOCK server for integrated protein–protein docking.″ Nature Protocols, 15: 1829-1852. DOI: https://doi.org/10.1038/s41596-020-0312-x.
Yi, M.S., Mrus, J.M., Wade, T.J., Ho, M.L., Hornung, R.W., Cotton, S., Peterman, A.H., Puchalski, C.M. and J. Tsevat, (2006). ″Religion, spirituality, and depressive symptoms in patients with HIV/AIDS.″ Journal of General Internal Medicine, 21(S5): S21-S27. DOI: https://doi.org/10.1111/j.1525-1497.2006.00643.x.
Yoshizawa, T., Shimizu, T., Yamabe, M., Taichi, M., Nishiuchi, Y., Shichijo, N., Unzai, S., Hirano, H., Sato, M. and H. Hashimoto, (2011). ″Crystal structure of basic 7S globulin, a xyloglucan‐specific endo‐β‐1, 4‐glucanase inhibitor protein‐like protein from soybean lacking inhibitory activity against endo‐β‐glucanase.″ The FEBS Journal, 278(11): 1944-1954. DOI: https://doi.org/10.1111/j.1742-4658.2011.08111.x.
Zhou, F., Zhang, H., Cong, Z., Zhao, L.-H., Zhou, Q., Mao, C., Cheng, X., Shen, D.-D., Cai, X. and C. Ma, (2020). ″Structural basis for activation of the growth hormone-releasing hormone receptor.″ Nature Communications, 11: 5205 (1-10). DOI: https://doi.org/10.1038/s41467-020-18945-0.
- Abstract Viewed: 124 times
- PDF Downloaded: 95 times